全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Prevalence, Causes and Management of Neovascular Glaucoma: A 5-Year Review

DOI: 10.4236/ojoph.2019.91001, PP. 1-8

Keywords: Anti-VEGF, Cyclophotocoagulation, Neovascular Glaucoma, Posterior Segment Ischaemia, Rubeosis Iridis, Retinal Vein Occlusion, Proliferative Diabetic Retinopathy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Purpose: To determine the prevalence, identify the causes and outline the management options available at our center for the treatment of neovascular glaucoma. Setting: The study was carried out in the department of ophthalmology, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria. Methods: The case records of all patients who were managed in the department of ophthalmology from January 2013 to December 2017 for neovascular glaucoma were retrieved. Data collected included, age, sex, causes of neovascular glaucoma, presenting visual acuity, treatment options and outcomes, systemic and ocular comorbidities. Results were analysed using Statistical Package for Social Sciences (SPSS) 20.0 for Windows statistical software. Results: Thirty-two eyes (32) of twenty-eight patients were studied. The hospital prevalence of neovascular glaucoma was 0.3%. There were 4 cases of bilateral neovascular glaucoma (NVG). Retinal vein occlusion 17 (53%) was the commonest cause of NVG followed by proliferative diabetic retinopathy 13 (41%). Uveitis was seen in only 2 (6%) eyes. The commonest form of intervention used was a combination of medical therapy and anti VEGFs. Fifty percent (50%) of the study population had a lowering of their intraocular pressures within the normal limits post treatment and this was statistically significant (p = 0.000). However, only 10% had an improvement in their visual acuity after treatment. Conclusions: Neovascular glaucoma is a potential blinding condition with challenges in control of intraocular pressures and preservation of vision. Early detection and attention to aetiological factors with timely institution of the appropriate mode of treatment may help in preserving vision.

References

[1]  Shazly, T.A. and Latina, M.A. (2009) Neovascular Glaucoma: Etiology, Diagnosis and Prognosis. Seminars in Ophthalmology, 24, 113-121.
https://doi.org/10.1080/08820530902800801
[2]  Rodrigues, G.B., Abe, R.Y., Zangalli, C., et al. (2016) Neovascular Glaucoma: A Review. International Journal of Retina and Vitreous, 2, 26.
https://doi.org/10.1186/s40942-016-0051-x
[3]  Weiss, D.I., Shaffer, R.N. and Nehrenberg, T.R. (1963) Neovascular Glaucoma Complicating Carotid-Cavernous Sinus Fistula. Archives of Ophthalmology, 69, 304.
https://doi.org/10.1001/archopht.1963.00960040310007
[4]  Kim, Y.H., Sung, M.S. and Park, S.W. (2017) Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma. Korean Journal of Ophthalmology, 31, 343-350.
[5]  Ashaye, A. and Adeoti, C.O. (2006) Neovascular Glaucoma in a Nigerian African Population. East African Medical Journal, 83, 559-564.
[6]  Fiebai, B., Ejimadu, C.S. and Komolafe, R.D. (2014) Incidence and Risk Factors for Retinal Vein Occlusion at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria. Nigerian Journal of Clinical Practice, 17, 462-466.
https://doi.org/10.4103/1119-3077.134040
[7]  Al-Bahlal, A., Khandekar, R., Al Rubaie, K., Alzahim, T., Edward, D.P. and Kozak, I. (2017) Changing Epidemiology of Neovascular Glaucoma from 2002 to 2012 at King Khaled Eye Specilaist Hospital, Saudi Arabia. Indian Journal of Ophthalmology, 65, 969-973.
[8]  Panya, H.K. (2018) Neovascular Glaucoma.
http://emedicine.medscape.com/article
[9]  Fiebai, B. and Odogu, V. (2017) Intravitreal Anti Vascular Endothelial Growth Factors in the Management of Retinal Diseases: An Audit. The Open Ophthalmology Journal, 11, 315-321.
[10]  Sun, Y.Y., Liang, Y., Zhou, P., Wu, H.J., Hou, X.R., Ren, Z.Q., Li, X.X. and Zhao, M.W. (2016) Anti-VEGF Treatment Is the Key Strategy for Neovascular Glaucoma Management in the Short Term. BMC Ophthalmology, 16, 150.
https://doi.org/10.1186/s12886-016-0327-9
[11]  Kaewkraisorn, C. and Sayawat, N. (2014) Prevalence of Neovascular Glaucoma in Srinagarind Hospital. Srinagarind Medical Journal, 29, 97.
[12]  Narayanaswamy, A., Baskaran, M., Zheng, Y., Lavanya, R., Wu, R., Wong, W.L., et al. (2013) The Prevalence and Types of Glaucoma in an Urban Indian Population: The Singapore Indian Eye Study. Investigative Ophthalmology & Visual Science, 54, 4621-4627.
https://doi.org/10.1167/iovs.13-11950
[13]  Landers, J., Henderson, T. and Craig, J. (2012) The Prevalence of Glaucoma in Indigenous Australians within Central Australia: The Central Australian Ocular Health Study. British Journal of Ophthalmology, 96, 162-166.
[14]  Ashaye, A., Ashaolu, O., Komolafe, O., Ajayi, B.G., Olawoye, O., Olusanya, B., et al. (2013) Prevalence and Types of Glaucoma among an Indigenous African Population in Southwestern Nigeria. Investigative Ophthalmology & Visual Science, 54, 7410-7416.
https://doi.org/10.1167/iovs.13-12698
[15]  Rotimi-Samuel, A., Onakoya, A.O., Musa, K.O., Aribaba, O.T. and Akinsola, F.B. (2014) Neo-Vascular Glaucoma: Etiology and Treatment Outcomes in Lagos. Nigerian Journal of Ophthalmology, 22, 16-19.
https://doi.org/10.4103/0189-9171.142749
[16]  Liao, N., Li, C., Jiang, H., Fang, A., Zhou, S. and Wang, Q. (2016) Neovascular Glaucoma: A Retrospective Review from a Tertiary Center in China. BMC Ophthalmology, 16, 14. https://doi.org/10.1186/s12886-016-0190-8

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133